Please login to the form below

Not currently logged in
Email:
Password:

PureTech Health appoints chief scientific officer

Dr Joseph Bolen brings 30 years of clinical experience to the biotech

PureTech Health Dr Joseph BolenBoston, US-based PureTech Health has appointed Dr Joseph Bolen as its chief scientific officer.

Dr Bolen will be responsible for the scientific development and advancement of PureTech Health's pipeline, working with the company's scientific advisory board and R&D team.

Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.

Prior to this, Dr Bolen was chief scientific officer and global head of oncology research at Millennium, Takeda's oncology business, and has held senior R&D positions at Bristol-Myers Squibb, Hoechst Marion Roussel and Schering-Plough.

Daphne Zohar, chief executive officer of PureTech Health, said: “We are tremendously excited to bring Joe's visionary leadership and drug development expertise to PureTech.

“Joe is a seasoned industry expert who brings the ideal balance of rigor and creativity to the role of chief scientific officer, and shares our vision for identifying and nurturing innovation that can potentially redefine healthcare.”

4th November 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics